Topics
Glioblastoma | Etiopathogenesis | Progression
Home > Publications > Topics > Glioblastoma > Etiopathogenesis > Progression
Wang S, Gu S, Chen J, Yuan Z, Liang P, Cui H.
Mechanism
of Notch Signaling Pathway in Malignant Progression of
Glioblastoma and Targeted Therapy.
Biomolecules.
2024 Apr 15;14(4):480. doi:
10.3390/biom14040480. PMID:
38672496.
Review.
ˍ
Mohamed AH, Obeid RA, Fadhil AA, Amir AA, Adhab ZH, Jabouri EA,
Ahmad I, Alshahrani MY.
BTLA and HVEM:
Emerging players in the tumor microenvironment and cancer
progression.
Cytokine.
2023 Oct 28;172:156412. doi:
10.1016/j.cyto.2023.156412. PMID:
39492110. Review˰ ˍ
Li J, Wu W, Ye L, Zheng B.
Hyperglycemia
as driver of glioblastoma progression: Insights from Mendelian
randomization and single-cell transcriptomics.
Brain
Res. 2025 Apr 8;1858:149636. doi:
10.1016/j.brainres.2025.149636. PMID:
40210146. Laboratory investigation˰
ˍ
Xia P.
The significance of
epithelial-mesenchymal transition (EMT) in the initiation,
plasticity, and treatment of glioblastoma.
Genes
Dis. 2025 Jun 6;13(1):101711. doi:
10.1016/j.gendis.2025.101711. PMID:
41141394. Review. ˍ
Silver DJ, Poplawski GHD, Lathia JD.
Opposing
Functions of White Matter in Glioblastoma.
Neuro
Oncol. 2025 Nov 14:noaf266. doi:
10.1093/neuonc/noaf266. PMID:
41234043. Editorial. ˍ
Khafaga DSR, Basem Y, AlAtar HM, Sherif A, Ata A, Sabry F,
El-Morsy MT, Attia SS.
Cancer
Neuroscience: Linking Neuronal Plasticity with Brain Tumor Growth
and Resistance.
Biology
(Basel). 2026 Jan 6;15(2):108. doi:
10.3390/biology15020108. PMID:
41594844. Review. ˍ
Kurdi M, Kabli A, Alkhotani A, Alkhotani A, Bokhari R, Jastaniah
Z, Amjad R, Althoukhi H, Alsinani T, Alamoudi H, Baeesa S.
Impact
of corticosteroid administration on glioblastoma progression
before and after adjuvant treatments: recent updates on
contradictory findings and mechanistic interactions.
Front
Oncol. 2026 Mar 2;16:1774736. doi:
10.3389/fonc.2026.1774736. PMID:
41847699. ˍ